Owkin Announces Partnership with AstraZeneca to Develop an AI gBRCA Pre-Screen Solution for Breast Cancer
recent articles
Paige: Six new advisors include leading experts in pathology, oncology, deep learning and global biopharmaceutical industry NEW YORK–(BUSINESS WIRE)–Paige, a global leader in AI applications in pathology, today...
Lunaphore and Visiopharm: Partnership to unify spatial staining and imaging with AI analysis technologies in end-to-end solution for researchers studying cancer and other diseases. LAUSANNE, Switzerland and HØRSHOLM, Denmark – May 4, 2022...
PathologyNOW: For decades the medical community has been reliant on the expertise of the pathologist. Almost 80% of all medical procedures require an element of pathology. However, when it comes to how users value the service, the populace...
Creative Bioarray announced the release of its comprehensive biospecimens to satisfy diverse biological research needs. New York, USA – May 2, 2022 – Histobiolab, the mature division of Creative Bioarray, developing a well-equipped...
A new way of using artificial intelligence to predict cancer from patient data without putting personal information at risk has been developed. Artificial intelligence (AI) can analyse large amounts of data, such as images or trial...
PathPresenter: Pilot installation at The Ohio State University integrates ClinPx into Epic’s Beaker Laboratory Information System (LIS), allowing The Ohio State University (OSU) pathologists to receive, view, and sign out cases – uploaded...
